The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
Open accessAbstract
BACKGROUND: Bronchiectasis develops early in the course of cystic fibrosis, being detectable in infants as young as 10 weeks of age, and is persistent and progressive. We sought to determine risk factors for the onset of bronchiectasis, using data collected by the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) intensive surveillance program. METHODS: We examined data from 127 consecutive infants who received a diagnosis of cystic fibrosis after newborn screening. Chest computed tomography (CT) and bronchoalveolar lavage (BAL) were performed, while the children were in stable clinical condition, at 3 months and 1, 2, and 3 years of age. Longitudinal data were used to determine risk factors associated with the detection of bronchiectasis from 3 months to 3 years of age. RESULTS: The point prevalence of bronchiectasis at each visit increased from 29.3% at 3 months of age to 61.5% at 3 years of age. In multivariate analyses, risk factors for bronchiectasis were presentation with meconium ileus (odds ratio, 3.17; 95% confidence interval [CI], 1.51 to 6.66; P=0.002), respiratory symptoms at the time of CT and BAL (odds ratio, 2.27; 95% CI, 1.24 to 4.14; P=0.008), free neutrophil elastase activity in BAL fluid (odds ratio, 3.02; 95% CI, 1.70 to 5.35; P<0.001), and gas trapping on expiratory CT (odds ratio, 2.05; 95% CI, 1.17 to 3.59; P=0.01). Free neutrophil elastase activity in BAL fluid at 3 months of age was associated with persistent bronchiectasis (present on two or more sequential scans), with the odds seven times as high at 12 months of age and four times as high at 3 years of age. CONCLUSIONS: Neutrophil elastase activity in BAL fluid in early life was associated with early bronchiectasis in children with cystic fibrosis. (Funded by the National Health and Medical Research Council of Australia and Cystic Fibrosis Foundation Therapeutics.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Papayannopoulos, V., Metzler, K. D., Hakkim, A., & Zychlinsky, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006052 · Cited by 2,103
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening
Sly, P. D., Brennan, S., Gangell, C., de Klerk, N., Murray, C., Mott, L., Stick, S. M., Robinson, P. J., Robertson, C. F., & Ranganathan, S. C. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0069oc · Cited by 555
Self-citationOwen, C. A., Campbell, M. A., Sannes, P. L., Boukedes, S. S., & Campbell, E. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.3.775 · Cited by 381
Stick, S. M., Brennan, S., Murray, C., Douglas, T., von Ungern-Sternberg, B. S., Garratt, L. W., Gangell, C. L., De Klerk, N., Linnane, B., Ranganathan, S., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.005 · Cited by 335
Self-citationde Jong, P. A., Nakano, Y., Lequin, M. H., Mayo, J. R., Woods, R., Paré, P. D., & Tiddens, H. A. W. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00006603 · Cited by 318
Neutrophils and Protease/Antiprotease Imbalance
STOCKLEY, R. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.supplement_1.13 · Cited by 292
Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis
Pillarisetti, N., Williamson, E., Linnane, B., Skoric, B., Robertson, C. F., Robinson, P., Massie, J., Hall, G. L., Sly, P., Stick, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1892oc · Cited by 287
Self-citationMott, L. S., Park, J., Murray, C. P., Gangell, C. L., de Klerk, N. H., Robinson, P. J., Robertson, C. F., Ranganathan, S. C., Sly, P. D., Stick, S. M., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200912 · Cited by 278
Self-citation
Cited by
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Shteinberg, M., Haq, I. J., Polineni, D., & Davies, J. C. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32542-3 · Cited by 682
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.003 · Cited by 496
Chalmers, J. D., Moffitt, K. L., Suarez-Cuartin, G., Sibila, O., Finch, S., Furrie, E., Dicker, A., Wrobel, K., Elborn, J. S., Walker, B., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201605-1027oc · Cited by 416
Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives
Khan, A. A., Alsahli, M. A., & Rahmani, A. H. (2018) · Medical Sciences · doi:10.3390/medsci6020033 · Cited by 410
Muco-Obstructive Lung Diseases
Boucher, R. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1813799 · Cited by 398
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure
Henderson, A. G., Ehre, C., Button, B., Abdullah, L. H., Cai, L.-H., Leigh, M. W., DeMaria, G. C., Matsui, H., Donaldson, S. H., Davis, C. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73469 · Cited by 326
Ong, T., & Ramsey, B. W. (2023) · JAMA · doi:10.1001/jama.2023.8120 · Cited by 315
Rosenfeld, M., Wainwright, C. E., Higgins, M., Wang, L. T., McKee, C., Campbell, D., Tian, S., Schneider, J., Cunningham, S., Davies, J. C., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30202-9 · Cited by 273
CFTR: cystic fibrosis and beyond
Mall, M. A., & Hartl, D. (2014) · European Respiratory Journal · doi:10.1183/09031936.00228013 · Cited by 259
Cystic fibrosis: a clinical view
Castellani, C., & Assael, B. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2393-9 · Cited by 254
Cystic Fibrosis Lung Disease: An Overview
Turcios, N. L. (2020) · Respiratory Care · doi:10.4187/respcare.06697 · Cited by 217
Sanders, D. B., & Fink, A. K. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.001 · Cited by 109
Thee, S., Stahl, M., Fischer, R., Sutharsan, S., Ballmann, M., Müller, A., Lorenz, D., Urbanski-Rini, D., Püschner, F., Amelung, V. E., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01500-y · Cited by 25
The long and winding road: stem cells for cystic fibrosis
Conese, M., Beccia, E., Castellani, S., Di Gioia, S., Colombo, C., Angiolillo, A., & Carbone, A. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1413087 · Cited by 15
Metadata
- Authors
- Sly, P. D., Gangell, C. L., Chen, L., Ware, R. S., Ranganathan, S., Mott, L. S., Murray, C. P., & Stick, S. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-05-23
- Volume
- 368
- Issue
- 21
- Pages
- 1963-1970
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2144292013
- Cited by
- 595
- References
- 24
- FWCI
- 39.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.